SE436037B - Sett att framstella nya 11-desoxi-prostaglandin-f?712-derivat - Google Patents

Sett att framstella nya 11-desoxi-prostaglandin-f?712-derivat

Info

Publication number
SE436037B
SE436037B SE7704616A SE7704616A SE436037B SE 436037 B SE436037 B SE 436037B SE 7704616 A SE7704616 A SE 7704616A SE 7704616 A SE7704616 A SE 7704616A SE 436037 B SE436037 B SE 436037B
Authority
SE
Sweden
Prior art keywords
desoxi
prostaglandin
derivative
make new
new
Prior art date
Application number
SE7704616A
Other languages
English (en)
Other versions
SE7704616L (sv
Inventor
J Buendia
J Nierat-Schalbar
R Deroy
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7612942A external-priority patent/FR2349328A1/fr
Priority claimed from FR7701299A external-priority patent/FR2377395A2/fr
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of SE7704616L publication Critical patent/SE7704616L/sv
Publication of SE436037B publication Critical patent/SE436037B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/32—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/3804—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se) not used, see subgroups
    • C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
SE7704616A 1976-04-30 1977-04-21 Sett att framstella nya 11-desoxi-prostaglandin-f?712-derivat SE436037B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7612942A FR2349328A1 (fr) 1976-04-30 1976-04-30 Nouveaux derives de la 11-desoxy prostaglandine f2, leur procede de preparation et leur application comme medicaments
FR7701299A FR2377395A2 (fr) 1977-01-18 1977-01-18 Nouveaux derives de la 11-desoxy prostaglandine f2, leur procede de preparation et leur application comme medicaments

Publications (2)

Publication Number Publication Date
SE7704616L SE7704616L (sv) 1977-10-31
SE436037B true SE436037B (sv) 1984-11-05

Family

ID=26219428

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7704616A SE436037B (sv) 1976-04-30 1977-04-21 Sett att framstella nya 11-desoxi-prostaglandin-f?712-derivat

Country Status (14)

Country Link
US (1) US4119727A (sv)
JP (1) JPS52148048A (sv)
AR (1) AR222627A1 (sv)
AT (1) AT355739B (sv)
AU (1) AU511408B2 (sv)
CA (1) CA1100493A (sv)
CH (1) CH620675A5 (sv)
DE (1) DE2719244A1 (sv)
DK (1) DK187677A (sv)
GB (1) GB1538842A (sv)
IE (1) IE45141B1 (sv)
LU (1) LU77240A1 (sv)
NL (1) NL7704758A (sv)
SE (1) SE436037B (sv)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0282901U (sv) * 1988-12-12 1990-06-27
US7179820B2 (en) * 2003-06-06 2007-02-20 Allergan, Inc. Piperidinyl prostaglandin E analogs
TW200602337A (en) 2004-02-25 2006-01-16 Wyeth Corp Inhibitors of protein tyrosine phosphatase 1B
WO2005081960A2 (en) * 2004-02-25 2005-09-09 Wyeth Inhibitors of protein tyrosine phosphatase 1b
US7183310B2 (en) 2004-08-10 2007-02-27 Allergan, Inc. Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US7906552B2 (en) 2004-08-10 2011-03-15 Allergan, Inc. Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US7101904B2 (en) * 2004-08-10 2006-09-05 Allergan, Inc. Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents
ATE465986T1 (de) * 2005-01-14 2010-05-15 Allergan Inc Substituierte cyclopentane oder cyclopentanone zur behandlung von augenhochdruck
EP2308495A1 (en) * 2005-03-04 2011-04-13 Sucampo AG Method and composition for treating peripheral vascular diseases
EP1960353B1 (en) 2005-11-03 2014-03-12 Allergan, Inc. Prostaglandins and analogues as agents for lowering intraocular pressure
AU2009246573B2 (en) * 2008-05-15 2014-04-24 Allergan, Inc. Therapeutic substituted cyclopentanes
EP2923756B1 (en) 2012-11-26 2018-05-30 Braskem S.A. Metallocene catalyst supported by hybrid supporting means, process for producing same, polymerization process for producing an ethylene homopolymer or copolymer with broad or bimodal molar mass distribution, use of the supported metallocene catalyst and ethylene polymer with broad or bimodal molar mass distribution

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3776940A (en) * 1966-08-09 1973-12-04 G Just Intermediates for producing prostaglandins
US3956284A (en) * 1972-07-13 1976-05-11 Pfizer Inc. Heterocyclic 15-substituted-ω-pentanorprostoglandins
US3794664A (en) * 1972-08-17 1974-02-26 G Just Bicyclo(3.1.0)hexane intermediates for producing prostaglandins f1alpha and f1beta
US4387241A (en) * 1974-11-01 1983-06-07 American Cyanamid Company Novel 16-aryloxy-17,18,19,20-tetranorprostanoic acids and derivatives

Also Published As

Publication number Publication date
SE7704616L (sv) 1977-10-31
DK187677A (da) 1977-10-31
JPS6131103B2 (sv) 1986-07-17
ATA310177A (de) 1979-08-15
US4119727A (en) 1978-10-10
IE45141L (en) 1977-10-30
GB1538842A (en) 1979-01-24
NL7704758A (nl) 1977-11-01
AR222627A1 (es) 1981-06-15
IE45141B1 (en) 1982-06-30
JPS52148048A (en) 1977-12-08
AT355739B (de) 1980-03-25
AU511408B2 (en) 1980-08-21
CA1100493A (fr) 1981-05-05
CH620675A5 (sv) 1980-12-15
DE2719244A1 (de) 1977-11-17
LU77240A1 (sv) 1977-12-13
AU2479577A (en) 1978-11-09
DE2719244C2 (sv) 1987-10-15

Similar Documents

Publication Publication Date Title
SE441528B (sv) Sett att framstella nya 3-kinolin-karboxylsyraderivat
SE436425B (sv) Sett att framstella nya spirolaktoner
SE440779B (sv) Sett att framstella androstan-17-on-derivat
SE431935B (sv) Sett att framstella drageer
SE435928B (sv) Sett att framstella nya 3-aryl-oxazolidin-2-oner
SE441042B (sv) Sett att pavisa rheumatoida faktorer
SE425736B (sv) Sett att framstella kromanon-(4)
SE432256B (sv) Sett att framstella cellulosaalkyletrar
SE430687B (sv) Sett att framstella hexanitrostilben
SE436037B (sv) Sett att framstella nya 11-desoxi-prostaglandin-f?712-derivat
SE7602729L (sv) Sett att framstella nya indolylalkylpiperidiner
SE7706488L (sv) 4-hydroxi-aporfin-derivat
SE420732B (sv) Sett att framstella 4-gonen-3-oner
SE434842B (sv) Sett att framstella nya 7-amino-tiazolyl-acetamido-cefalosporansyraderivat
SE424991B (sv) Sett att framstella nya 5-fenyl-oxazolidinoner
SE425321B (sv) Sett att reducera vanadinoxider
SE7705986L (sv) Sett att framstella nya aryltrifluoretyaminer
SE434397B (sv) Sett att framstella bens-acyl-bensimidazol-2-derivat
SE433213B (sv) Sett att framstella 2 -fenyl-3-amino-benso/b/tiofenderivat
SE8300446D0 (sv) Sett att framstella nya aminoalkoxibensofuraner
SE412233B (sv) Sett att framstella nya fenotiazinderivat
SE7613991L (sv) Sett att framstella nya substituerade indoler
SE7713906L (sv) Sett att framstella nya piperazinderivat
SE7609666L (sv) Sett att framstella nya 5-aminometyltiazolderivat
SE442633B (sv) Sett att framstella alfa-cyano-3-fenoxibensylkarboxylat

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7704616-7

Effective date: 19910117

Format of ref document f/p: F